Jiangsu Cowin Biotech Co., Ltd. (688426.SH) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostics Technology Co., Ltd., has received a Class III Medical Device Registration Certificate for In Vitro Diagnostic Reagents from the National Medical Products Administration for its self-developed Nine Respiratory Pathogen Nucleic Acid Detection Kit (Fluorescent PCR Method). According to the announcement, this product utilizes fluorescent quantitative PCR technology and advanced freeze-drying methods to qualitatively detect nucleic acids from nine pathogens in human throat swab samples. The pathogens detected include Influenza A virus, Influenza B virus, Respiratory Syncytial Virus, Human Rhinovirus, Mycoplasma pneumoniae, Adenovirus, Parainfluenza Virus Type I, Parainfluenza Virus Type II, and Parainfluenza Virus Type III.